GGrantIndex
← Leaderboards

Lisa R Tannock

University Of Washington

$4,109,667
Attributed
$4,862,032
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY200722
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$4,862,032 · 5
VA$0 · 3

By mechanism

R01$4,408,973 · 3
R21$380,000 · 1
P20$73,059 · 1
I01$0 · 3

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Proteoglycan

Research focus

ProteoglycanDiabetes MellitusAtherosclerosisLipoproteinsIn VivoLow-Density LipoproteinsMouse ModelIn VitroRisk FactorsGrantCardiovascular DiseasesBlood VesselsResponseEventBinding (Molecular Function)Apolipoproteins BInflammatoryReportingMacrophageBiglycanHigh PrevalenceObesityLinkMediating

Grant awards (26)

Mechanisms regulating the atherogenic activities of serum amyloid A$501,577
R01 · FY2022 · HL · contact PI
Mechanisms regulating the atherogenic activities of serum amyloid A$501,577
R01 · FY2021 · HL · contact PI
Mechanisms linking obesity and abdominal aortic aneurysm$0
I01 · FY2021 · VA · contact PI
Mechanisms regulating the atherogenic activities of serum amyloid A$501,577
R01 · FY2020 · HL · contact PI
Mechanisms linking obesity and abdominal aortic aneurysm$0
I01 · FY2020 · VA · contact PI
Mechanisms linking obesity and abdominal aortic aneurysm$0
I01 · FY2019 · VA · contact PI
The association of SAA with apoB lipoproteins affects cardiovascular risk$0
I01 · FY2017 · VA · contact PI
The association of SAA with apoB lipoproteins affects cardiovascular risk$0
I01 · FY2016 · VA · contact PI
The association of SAA with apoB lipoproteins affects cardiovascular risk$0
I01 · FY2015 · VA · contact PI
The association of SAA with apoB lipoproteins affects cardiovascular risk$0
I01 · FY2014 · VA · contact PI
Mechanisms of Renal Lipid Accumulation in Diabetic Nephropathy$0
I01 · FY2013 · VA · contact PI
Mechanisms of Renal Lipid Accumulation in Diabetic Nephropathy$0
I01 · FY2012 · VA · contact PI
Angiotensin Induced Proteoglycans in Atherosclerosis$366,250
R01 · FY2011 · HL · contact PI
Mechanisms of Renal Lipid Accumulation in Diabetic Nephropathy$0
I01 · FY2011 · VA · contact PI
Role of Serum Amyloid A in Atheroscierosis$392,745
R01 · FY2010 · HL · contact PI
Angiotensin Induced Proteoglycans in Atherosclerosis$366,250
R01 · FY2010 · HL · contact PI
Role of Serum Amyloid A in Atheroscierosis$406,492
R01 · FY2009 · HL · contact PI
Angiotensin Induced Proteoglycans in Atherosclerosis$366,250
R01 · FY2009 · HL · contact PI
Angiotensin Induced Proteoglycans in Atherosclerosis$273,755
R01 · FY2009 · HL · contact PI
Mechanisms of Renal Lipid Accumulation in Diabetic Nephropathy$0
I01 · FY2009 · VA · contact PI
Angiotensin Induced Proteoglycans in Atherosclerosis$366,250
R01 · FY2008 · HL · contact PI
Angiotensin Induced Proteoglycans in Atherosclerosis$366,250
R01 · FY2007 · HL · contact PI
MECHANISMS OF RENAL LIPID RETENTION IN DIABETIC NEPHROPATHY$73,059
P20 · FY2007 · RR · contact PI
Glucosamine, Proteoglycan Synthesis and Atherosclerosis$105,124
R21 · FY2002 · AT
Glucosamine, Proteoglycan Synthesis and Atherosclerosis$84,876
R21 · FY2002 · AT
Glucosamine, Proteoglycan Synthesis and Atherosclerosis$190,000
R21 · FY2001 · AT